Kodiak Sciences Inc. Income Statement
KOD / Health Care|9 years of annual SEC 10-K data (FY2016-FY2024)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 9 fiscal years. All figures from audited SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|
| SG&A Expense | $60.8M | $71.0M | $73.8M | $49.7M | $28.6M | $11.7M | $7.6M | $3.5M | $3.1M |
| R&D Expense | $126.1M | $206.3M | $267.6M | $217.3M | $107.4M | $37.5M | $18.8M | $22.0M | $14.1M |
| Operating Income | -$186.8M | -$277.3M | -$341.4M | -$267.1M | -$136.0M | -$49.2M | -$26.4M | -$25.5M | -$17.2M |
| Interest Expense | $0 | $13.0K | $18.0K | $47.0K | $25.0K | $8.0K | $5.5M | $1.2M | $6.0K |
| Income Tax | $20.0K | $33.0K | $33.0K | $74.0K | $14.0K | - | - | - | - |
| Net Income | -$176.2M | -$260.5M | -$333.8M | -$267.0M | -$133.1M | -$47.4M | -$41.4M | -$27.9M | -$17.1M |
| EPS (Basic) | -$3.35 | -$4.97 | -$6.39 | -$5.16 | -$2.91 | - | - | - | - |
| EPS (Diluted) | -$3.35 | -$4.97 | -$6.39 | -$5.16 | -$2.91 | - | - | - | - |
| Shares Outstanding | 52.6M | 52.4M | 52.2M | 51.8M | 45.7M | 37.9M | 15.0M | 7.5M | 7.2M |